ArticleCancer research and treatment2023

Expanded Access Program Pralsetinib in Advanced Non-Small Cell Lung Cancer with Rearranged during Transfection (RET) Gene Rearrangement.

Youngkyung Jeon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.